Apr 3, 2017

Corporate uncertainty over healthcare reform soars

Protesting Obamacare repeal (Tanya Moutzalias/The Ann Arbor News-MLive.com)

Corporate America is increasingly worried about healthcare reform, according to Michelle Leder of Footnoted. She points out in a recent blog post that mentions of the Affordable Care Act in corporate financial disclosures are on pace to reach an all-time high in 2017.

Data: Footnoted.com; Chart: Andrew Witherspoon / Axios

Predictably, the firms most worried about the fate of the law include health insurers, hospitals, and pharmaceutical companies. But the anxiety didn't end there, as companies from human resources consultant Robert Half International to the Cheesecake Factory have warned their investors that reform could adversely affect their health care costs or simply hurt the economy overall.

Go deeper

Health care profits dip, but stocks soar

Data: FactSet; Chart: Axios Visuals

Health care industry earnings fell 18% in the third quarter of this year, compared with the same period in 2018, due in part to the costs associated with opioids litigation, according to the Axios tracker of almost 170 health care companies.

Yes, but: The industry still churned out a 6.1% profit margin, and health care stocks are at the highest they've been all year because Wall Street foresees a very profitable election year.

Go deeperArrowDec 17, 2019

Health care IPOs had a very good 2019

Data: Yahoo Finance; Chart: Andrew Witherspoon/Axios

Two-thirds of the 68 health care companies that went public in 2019 traded above their IPO price by the end of year — many of which provided huge initial returns to owners and outside investors.

The big picture: The vast majority of health care companies that go public are biotechnology firms. Several of those biotechs in the 2019 class benefited from some promising, but extremely early, clinical trial data.

Go deeperArrowJan 9, 2020

Hospitals say they want affordable care, but actions aren't clear

Illustration: Aïda Amer/Axios

Hospitals acknowledged to investors at this year's J.P. Morgan Healthcare Conference that their industry is contributing to patients' financial turmoil.

Yes, but: Hospitals reassured those same investors that they were focused on growing their revenue, with no real details about how that would save patients money.

Go deeperArrowJan 14, 2020